New study aims to improve agitation measurement in mental health

NCT ID NCT07116694

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 28 times

Summary

This study looked at how well patients, their family members, and doctors agree when rating agitation episodes in people with bipolar disorder or schizophrenia. Thirty-three adults received a treatment called BXCL501, and researchers compared different questionnaires to see which ones work best. The goal was to find simpler, more reliable ways to measure agitation in future studies and clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • BioXcel Clinical Research Site 101

    St Louis, Missouri, 63125, United States

  • BioXcel Clinical Research Site 102

    Orange, California, 92868, United States

  • BioXcel Clinical Research Site 103

    Chino, California, 91710, United States

  • BioXcel Clinical Research Site 105

    Oceanside, California, 92056, United States

  • BioXcel Clinical Research Site 106

    Las Vegas, Nevada, 89119, United States

Conditions

The condition(s) this trial relates to.

bipolar disorder bipolar I disorder bipolar II disorder Psychomotor Agitation Psychotic Disorders schizoaffective disorder schizophrenia schizophreniform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.